Corrigendum to “Antithrombotic therapy after bioprosthetic aortic valve replacement: ACTION Registry survey results” [Eur. J. Cardiothorac. Surg. 33 (2008) 531–536]

Department of Cardiovascular Surgery, Hospital Clinic, Barcelona, Spain Department of Cardio-Vascular and Thoracic Surgery, University of Rennes, France Department of Cardiothoracic Surgery, St. Antonius Hospital, Nieuwegein, The Netherlands Department of Cardiac and Thoracic Surgery, University of Cologne, Germany Department of Cardiac Surgery, The Royal Sussex County Hospital, United Kingdom Department of Cardiothoracic Surgery, University Hospital Birmingham, United Kingdom Department of Cardiothoracic Surgery, University Hospital, Coimbra, Portugal Department of Thoracic and Cardiovascular Surgery, Heart Center North Rhine-Westphalia, Ruhr University of Bochum, Bad Oeynhausen, Germany Department of Cardiothoracic Surgery, Wessex Cardiothoracic Centre, Southampton General Hospital, Southampton, United Kingdom Department of Thoracic, Cardiac and Vascular Surgery, University of Tubingen, Germany Department of Cardiovascular Surgery, Pitie Salpetriere Hospital, University Pierre et Marie Curie, France Department of Cardio-Thoracic Surgery, Catharina Hospital, Eindhoven, The Netherlands Department of Cardiac Surgery, University of Parma, Italy